Insider selling

John M Leonard sold $287K of Intellia Therapeutics, Inc. (NTLA) stock

SEC Form 4 · Filed Aug 24, 2026

John M Leonard, President and CEO of Intellia Therapeutics, Inc. (NTLA), sold 22,675 shares of NTLA stock worth $287K, per an SEC Form 4 filed Aug 24, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Aug 20, 2026, 4 days before it was made public.

NTLA has moved +2.0% since the trade date, from $12.44 to $12.69 (Sep 22, 2026 close).

Sold

NTLA

Intellia Therapeutics, Inc.

Value

$287K

Traded: Aug 20, 2026
Disclosed: Aug 24, 2026
Filing delay: 4 days
Price since: +2.0%
Role: President and CEO
Source: SEC Form 4

See the filing

More NTLA insider and Congress trades

SellNTLA · Edward J Dulac III$91KJul 24, 2026
SellNTLA · Edward J Dulac III$84KJul 6, 2026
SellNTLA · Michael P Dube$44KJul 6, 2026

Share this trade

From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.